Considerations for AR-V7 testing in clinical routine practice

Affiliations

Editorial

Christof Bernemann et al. Ann Transl Med. 2019 Dec.

. 2019 Dec;7(Suppl 8):S378.

doi: 10.21037/atm.2019.12.136.

¹ Department of Urology, University of Muenster Medical Center, Muenster, Germany.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Sharp A, Welti JC, Lambros MBK, Dolling D, Rodrigues DN, Pope L, Aversa C, Figueiredo I, Fraser J, Ahmad Z, Lu C, Rescigno P, Kolinsky M, Bertan C, Seed G, Riisnaes R, Miranda S, Crespo M, Pereira R, Ferreira A, Fowler G, Ebbs B, Flohr P, Neeb A, Bianchini D, Petremolo A, Sumanasuriya S, Paschalis A, Mateo J, Tunariu N, Yuan W, Carreira S, Plymate SR, Luo J, de Bono JS. Sharp A, et al. Eur Urol. 2019 Nov;76(5):676-685. doi: 10.1016/j.eururo.2019.04.006. Epub 2019 Apr 27. Eur Urol. 2019. PMID: 31036442

1. Rathkopf D, Scher HI. Androgen receptor antagonists in castration-resistant prostate cancer. Cancer J 2013;19:43-9. 10.1097/PPO.0b013e318282635a - DOI - PMC - PubMed
1. Sumanasuriya S, De Bono J. Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise. Cold Spring Harb Perspect Med 2018;8. doi: .10.1101/cshperspect.a030635 - DOI - PMC - PubMed
1. Ware KE, Garcia-Blanco MA, Armstrong AJ, et al. Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer. Endocr Relat Cancer 2014;21:T87-T103. 10.1530/ERC-13-0470 - DOI - PMC - PubMed
1. Bastos DA, Antonarakis ES. AR-V7 and treatment selection in advanced prostate cancer: are we there yet?. Precis Cancer Med 2018. doi: .10.21037/pcm.2018.09.01 - DOI - PMC - PubMed
1. Antonarakis ES, Lu C, Wang H, et al. AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 2014;371:1028-38. 10.1056/NEJMoa1315815 - DOI - PMC - PubMed